Use of zoledronic acid in the treatment of Gorham's disease

Int J Pediatr Otorhinolaryngol. 2010 Mar;74(3):319-22. doi: 10.1016/j.ijporl.2009.12.007. Epub 2010 Jan 13.

Abstract

Gorham's disease (Gorham-Stout syndrome) is a rare condition of unknown etiology involving a localized endothelial proliferation of lymph vessels resulting in destruction with bone resorption. The syndrome is rarely seen in the facial skeleton and has a large variety of prognoses and treatments. A case of this syndrome in a 9-year-old boy is presented. The clinical aspects are described, together with the treatment involving zoledronic acid. Other treatments described in the literature are reviewed. The authors believe that this report is one of the first cases in which a child afflicted in the first decade of life survives.

Publication types

  • Case Reports

MeSH terms

  • Bone Density Conservation Agents / therapeutic use*
  • Child
  • Diphosphonates / therapeutic use*
  • Humans
  • Imidazoles / therapeutic use*
  • Male
  • Mandible / pathology
  • Osteolysis, Essential / drug therapy*
  • Osteolysis, Essential / pathology
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid